XENE — Xenon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Xenon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	177	552	592	638	627
Net Total Accounts Receivable
Net Total Receivables	1.82	2.77	0.986	0.874	1.47
Prepaid Expenses
Total Current Assets	182	559	600	645	635
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.88	12.5	16.9	18.8	18.2
Long Term Investments
Other Long Term Assets
Total Assets	189	572	754	965	798
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.8	14.3	22.7	27.3	35.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.8	22	32.6	36.9	43.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	171	550	721	928	755
Total Liabilities & Shareholders' Equity	189	572	754	965	798
Total Common Shares Outstanding
Total Preferred Shares Outstanding